By Karmactive Staff
MIT's new nanosensor technology transforms lung cancer detection by using a simple urine test post-inhalation.
By Karmactive Staff
Photo Source: Google
This approach could effectively supplement or replace CT scans, particularly beneficial in regions lacking medical infrastructure.
By Karmactive Staff
Photo Source: Google
Sangeeta Bhatia, a leading MIT professor, emphasizes the technology's global impact, especially in areas affected by pollution and smoking.
By Karmactive Staff
Photo Source: Google
Nanoparticles, when inhaled, interact with cancer-linked proteins, triggering a detectable signal in urine.
By Karmactive Staff
Photo Source: Google
The technology's ease of use and accessibility make it a potential game-changer for early cancer diagnosis worldwide.
By Karmactive Staff
Photo Source: Google
Results from the innovative urine test can be obtained in about 20 minutes, enhancing the efficiency of lung cancer screening.
By Karmactive Staff
Photo Source: Google
In mouse models, the new method accurately detected early-stage lung tumors, paving the way for human applications.
By Karmactive Staff
Photo Source: Google
A lateral flow assay enables the detection of DNA barcodes in urine, eliminating the need for complex equipment.
By Karmactive Staff
Photo Source: Google
MIT's breakthrough represents a significant stride in democratizing lung cancer screening in low-resource settings.
More Stories
Learn more